Jill Marie Broadfoot
CIK 1305178 · Chief Financial Officer · last filed 2026-06-24
Jill Marie Broadfoot is a Chief Financial Officer who has filed 42 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TLPH, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$85.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $696.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$696.9K
7
42
$85.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Director | 13,647 | $1.30 | $17.7K | $0 | 3 | 2026-06-24 |
| ATYR | Chief Financial Officer | 38,854 | $0.49 | $19.2K | -$1.5K | 1 | 2026-02-04 |
| LIFE | Chief Financial Officer | 35,104 | $18.80 | $660.0K | $86.0K | 21 | 2026-01-09 |
| CUE | Director | — | $30.25 | — | $0 | 2 | 2026-01-06 |
| TALPHERA, INC. (ACRX) Delisted | Director | 2,106 | $0.86 | $1.8K | $0 | 3 | 2023-12-13 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 2 | 2022-06-23 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sr Vice President, CFO, Sec | 20,807 | — | — | $961 | 10 | 2013-04-03 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | TLPH | Grant (A) | +5,100 | $0 | EDGAR |
| 2026-02-04 | ATYR | Mixed | +2,192 | -$1.5K | EDGAR |
| 2026-01-09 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | CUE | Grant (A) | — | $0 | EDGAR |
| 2025-10-24 | TLPH | Grant (A) | +4,267 | $0 | EDGAR |
| 2025-06-06 | CUE | Grant (A) | — | $0 | EDGAR |
| 2025-02-04 | LIFE | Mixed | +2,496 | -$4.7K | EDGAR |
| 2025-01-10 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | TLPH | Grant (A) | +2,174 | $0 | EDGAR |
| 2024-06-03 | LIFE | Buy (P) | +5,000 | $8.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.